Bluejay Investor Presentation Deck

Financial Highlights Financial Info (June 30, 2023) Cash* Est. Cash Runway Clean Balance Sheet BJDX (NASDAQ) (August 22, 2023) Market Cap Average Daily Trading Volume (30 day) Shares Outstanding Closing Price DIAGNOSTICS $5.1 M < 12 months No outstanding warrants or debt $7.6M 620K shares 1.0M $7.11 The Symphony™ System and SymphonyTM Cartridge have not been cleared or approved by the U.S. FDA Symphony Symphony L Symphony Symphony f yo Erbacity Sympheny 000 Kelanta Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | August 2023 18

View entire presentation